Wedbush Research Analysts Reduce Earnings Estimates for APLS
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Stock analysts at Wedbush lowered their Q2 2025 earnings estimates for shares of Apellis Pharmaceuticals in a report issued on Wednesday, May 7th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($0.50) for the quarter, down from their prior forecast […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Stock analysts at Wedbush lowered their Q2 2025 earnings estimates for shares of Apellis Pharmaceuticals in a report issued on Wednesday, May 7th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($0.50) for the quarter, down from their prior forecast […]
